Promoters hold 46.6% of Glenmark Pharmaceuticals Limited (GLENMARK). FIIs hold 20.9%, mutual funds 16.8% and other DIIs 1.8%. No promoter pledge is reported. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 46.6% | 46.6% | 46.6% | 46.6% | 46.6% | 46.6% | 46.6% | 46.6% | 46.6% | 46.6% | 46.6% | 46.6% |
| FII | 20.9% | 20.3% | 19.2% | 20.7% | 20.6% | 23.2% | 23.5% | 23.1% | 21.0% | 21.4% | 23.7% | 24.8% |
| MF | 16.8% | 16.8% | 17.9% | 16.3% | 15.6% | 12.9% | 12.1% | 11.4% | 10.9% | 10.6% | 8.6% | 7.3% |
| Other DII | 1.8% | 2.5% | 2.2% | 2.3% | 2.1% | 1.7% | 1.7% | 1.8% | 3.0% | 2.8% | 2.3% | 3.0% |
| Retail & others | 13.8% | 13.7% | 14.0% | 14.0% | 15.1% | 15.6% | 16.0% | 17.1% | 18.4% | 18.6% | 18.7% | 18.2% |
No bulk or block deals disclosed for this stock in the last 90 days.
Bulk deals are uncommon for large caps — a single client has to trade over 0.5% of the company's shares in one day. Most weeks, none happen.
No PIT or SAST disclosures on record for this stock in the last 12 months.
That is the usual state — promoters, directors and holders above 5% file only when they trade or pledge; a new filing appears here within a day of reaching the exchange.
In Jun 26, FII holding rose +0.6pp and mutual funds +0.0pp, while retail added +0.1pp. Rising institutional ownership is often read as “smart money” accumulation — though it’s never a guarantee.
Quarterly shareholding patternas of Jun 26
